Discovery of cahuitamycins as biofilm inhibitors derived from a convergent biosynthetic pathway
Guardado en:
| Autores: | , , , , , , , , , , , |
|---|---|
| 格式: | artículo original |
| Fecha de Publicación: | 2016 |
| 實物特徵: | Pathogenic microorganisms often have the ability to attach to a surface, building a complex matrix where they colonize to form a biofilm. This cellular superstructure can display increased resistance to antibiotics and cause serious, persistent health problems in humans. Here we describe a high-throughput in vitro screen to identify inhibitors of Acinetobacter baumannii biofilms using a library of natural product extracts derived from marine microbes. Analysis of extracts derived from Streptomyces gandocaensis results in the discovery of three peptidic metabolites (cahuitamycins A–C), with cahuitamycin C being the most effective inhibitor (IC50=14.5 μM). Biosynthesis of cahuitamycin C proceeds via a convergent biosynthetic pathway, with one of the steps apparently being catalysed by an unlinked gene encoding a 6-methylsalicylate synthase. Efforts to assess starter unit diversification through selective mutasynthesis lead to production of unnatural analogues cahuitamycins D and E of increased potency (IC50=8.4 and 10.5 μM). |
| País: | Kérwá |
| 機構: | Universidad de Costa Rica |
| Repositorio: | Kérwá |
| OAI Identifier: | oai:kerwa.ucr.ac.cr:10669/74422 |
| 在線閱讀: | https://www.nature.com/articles/ncomms10710 https://hdl.handle.net/10669/74422 |
| Palabra clave: | Biofilms Biosynthesis Natural products Peptides |